Fresenius Kabi AG - Company Profile
Powered by 
All the sales intelligence you need on Fresenius Kabi AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Fresenius Kabi AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Fresenius Kabi AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Fresenius Kabi AG (Fresenius Kabi), a subsidiary of Fresenius SE & Co KGaA, is a global healthcare company committed to delivering life-saving medicines and medical technologies. It specializes in intravenous (IV) drugs, medical nutrition, infusion technologies, cell therapies, blood collection, and biopharmaceuticals. The company provides a comprehensive portfolio aimed at improving patient care in emergency medicine, surgery, and intensive care across the world.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Fresenius Kabi's R&D activities focus on innovation and research through a decentralized organizational structure across different markets. The company invests in local innovation and education to promote sustainable economic growth and productive employment. Its major areas of focus include digitalization in healthcare, such as telemedicine, electronic health records, artificial intelligence, and digital health apps. The company is also committed to improving treatment efficiency and effectiveness through digital solutions like track-and-trace systems and device interoperability. The R&D units of Fresenius Kabi include the Enteral Nutrition Research and Development center in Gurugram, India, which focuses on faster product innovation in nutrition. The Wuxi, China center is a cornerstone for global clinical nutrition, focusing on parenteral nutrition, Foods for Special Medical Purposes (FSMP), and renal nutrition development. The upcoming KabiLab D20 in Bad Homburg, Germany, will drive global product development, including plant-based innovations and advanced technologies for personalized parenteral nutrition. Fresenius Kabi has three R&D centers located in Gurugram, India; Wuxi, China; and Bad Homburg, Germany.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer